Eyesouth, which is backed by Shore Capital Partners, invested in Georgia Eye Associates. Financial terms weren’t announced. Georgia Eye provides eye care services, including laser cataract surgery, glaucoma treatment, and diabetic eye management, at four clinical locations in Lawrenceville, Buckhead, Tucker and Braselton, Georgia.
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with Georgia Eye Associates, expanding its presence into the Lawrenceville and northeast Atlanta regions. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity firm. EyeSouth’s affiliate network consists of 63 doctors providing medical and surgical eye care services at 40 locations throughout Georgia, Florida, and North Carolina.
Georgia Eye Associates is led by physicians Donald Poland, M.D., Kris Gillian, M.D., and Frank Winski, O.D., who provide care at four clinical locations in Lawrenceville, Buckhead, Tucker and Braselton, Georgia. Georgia Eye Associates offers a full suite of eye care services including laser cataract surgery, glaucoma treatment, diabetic eye management, LASIK, oculoplastics, dry eye management and routine eye exams.
“Our partnership with EyeSouth is a key part of our long-term commitment to our patients and to constantly improving their quality of care,” said Dr. Donald Poland. “As part of the EyeSouth affiliation network, we will begin our next phase of growth with the dedicated support of EyeSouth. TheEyeSouth partnership will ensure access to the latest technologies, best-in-class administrative support, and industry-leading physician expertise. At Georgia Eye Associates, our goal has always been to improve the quality of our patients’ lives through better vision and EyeSouth will help us continue to achieve that goal.”
Dr. Donald Poland started providing eye care in the Lawrenceville community in 1988 and Georgia Eye Associates has been growing throughout northeast Atlanta ever since. Georgia Eye Associates will continue to operate under its brand, with no changes to its staff, physicians or locations.
“Drs. Poland, Gillian and Winski along with the entire Georgia Eye Associates team have rightfully earned a reputation for high quality patient care. We are looking forward to taking this partnership to the next level and providing our expertise and best practices to continue Georgia Eye Associates’ history of growth and quality care,” said Eugene Gabianelli, M.D., Chief Medical Officer of EyeSouth Partners.
To learn more about a partnership with EyeSouth Partners, visit www.eyesouthpartners.com or contact Charlie Shreve, VP of Business Development & Strategy, firstname.lastname@example.org.
About EyeSouth Partners
Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care physician services organization committed to partnering with leading physicians to build a premier network of eye care services in Georgia and the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with capital, administrative resources, operating expertise, and strategic guidance with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of 63 doctors practicing at 40 locations throughout Georgia, Florida, and North Carolina. EyeSouth is backed by Shore Capital Partners, a leading lower middle market healthcare private equity firm. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.
About Shore Capital Partners
Shore Capital is a Chicago-based private equity firm focused exclusively on microcap healthcare investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has approximately $600 million of equity capital under management through various investment vehicles. For more information, please visit: www.shorecp.com.